Effects of Antiarrhythmic Agents on Cardiac Function

Singh, B.N. , Vaughan-Williams, E.M. : A fourth class of antidysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials and on other features of cardiac function. Cardiovasc. Res., 6: 109, 1972.

Moe, G. , Abildskov, J. : Antiarrhythmic drugs, In The Pharmacologic Basis of Therapeutics . Edited by Goodman, L. , and Gilman, L. Ed. 3, New York, Mac-Millan, 1965, p. 619.

Angelakos, E.T. , Hastings, E.P. : The influence of quinidine and procaineamine on myocardial contractility in vivo. Am. J. Cardiol., 5: 791, 1960.

Folle, L.E. , Aviado, D.M. : The cardiopulmonary effects of quinidine and procaineamide. J. Pharmacol. Exp. Ther., 154: 92, 1966.

Mierzwiak, D. , Mitchell, J. , Shapiro, W. : The effect of diphenylhydantoin and quinidine on LV function in dogs. Am. Heart J., 74: 780, 1967.

Stern, S. : Hemodynamic changes following separate and combined administration of beta blocking drugs and quinidine. Eur. J. Clin. Invest., 1: 432, 1971.

Schmid, P.G. , Nelson, L.D. , Mark, A.L. , et al.: Inhibition of adrenergic vasoconstriction by quinidine. J. Pharmacol. Exp. Ther., 188: 124, 1974 .

Pruett, J.K. , Woods, E.F. : The relationship of intracellular depolarization rates and contractility in the dog ventricle in situ: Effects of positive and negative inotropic agents. J. Pharmacol. Exp. Ther., 157: 1, 1967.

Markiewicz, W. , Winkle, R. , Binetti, G. , et al.: Normal myocardial contractile state in the presence of quinidine. Circulation, 53: 101, 1976.

Engler, R.L. , Lewinter, M.M. , Karliner, J.S. : Depressant effects of quinidine gluconate in left ventricular function in conscious dogs with and without volume overload . Circulation, 60: 829, 1979.

Schroder, G. : Quinidine or hemodynamics in man—A double blind study of oral therapy with sustained release tablets for a week. Acta Med. Scand., 179: 543, 1966.

Mason, J.W. , Winkle, R.A. , Ingels, H.B. , et al.: Hemodynamic effects of intravenously administered quinidine on the transplanted human heart. Am. J. Cardiol., 40: 99, 1977.

Crawford, M.H. , White, D.H. , O'Rourke, R.A. : Effects of quinidine on left ventricular performance in normal subjects and patients with congestive cardiomyopathy . Am. J. Cardiol., 44: 714, 1979.

Cohen, I.S. , Jick, H. , Cohen, S.I. : Adverse reactions to quinidine in hospitalized patients: Findings based on data from the Boston Collaborative Drug Surveillance Program. Prog. Cardiovasc. Dis., 20: 191, 1977.

Nelson, D. , Harrison, D. : A comparison of the negative inotropic effects of procainamide, lidocaine and quinidine. Physiologist, 8: 241, 1965.

Bigger, J.T. , Jr., Heissenbuttel , R.H. : The use of procaineamide and lidocaine in the treatment of cardiac arrhythmias. Prog. Cardiovasc. Dis., 11: 515, 1969.

Hoffman, B.F. , Rosen, M.R. , Wit, A.L. : Electrophysiology and pharmacology of acute arrhythmias. VII. Cardiac effects of quinidine and procaineamide. Am. Heart J. 90: 117, 1975.

Jewitt, D.E. , Kishon, Y. , Thomas, M. : Lignocaine in the management of arrhythmia after acute myocardial infarction. Lancet, 1: 266, 1968.

Stannard, M. , Sloman, G. , Sangston, L. : Hemodynamic effects of lignocaine in acute myocardial infarction. Br. Med. J., 2: 468, 1968.

Naylor, W.R. : The pharmacology of disopyramide. J. Int. Med. Res., 4: 8, Suppl. 1, 1976.

Binetti, G. , Branzi, A. , Malini, P.L. , et al.: Hemodynamic effects of disopyramide and procaineamide in open chest animals. G. Ital. Cardiol. , 8: 1314, 1978.

Walsh, R.A. , Horwitz, L. : Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs. Circulation , 60: 1053, 1979.

Desai, J. , Hirshfeld, D. , Peters , et al.: Electromechanical dissociation associated with disopyramide (Abstract). Circulation , 57: 11, 1978.

Ross, D. , Vohra, J. , Sloman, J.G. : Disopyramide in myocardial infarction. Lancet, 2: 330, 1978.

Story, J. , Abdulla, A. , Frank, M. : Cardiogenic shock and disopyramide phosphate. JAMA, 242: 654, 1979.

Podrid, P.J. , Schoeneberger, A. , Lown, B. : Congestive heart failure caused by oral disopyramide . N. Engl. J. Med., 302: 614, 1980.

Wilson, R. : Personal communication. G. D. Searle and Co., 1980.

Sutton R. : Hemodynamics of intravenous disopyramide. J. Int. Med. Res. , 4: 46, Suppl. 1, 1976.

Jensen, G. , Sigurd, B. , Uhrenholt, A. : Hemodynamic effects of intravenous disopyramide. Eur. J. Clin. Pharmacol., 8: 167, 1975.

Jensen, G. , Sigurd, B. , Uhrenholt, A. : Circulatory effects of intravenous disopyramide in heart failure. J. Int. Med. Res. 4: 42, Suppl. 1, 1967.

Willis, P.W. : The hemodynamic effects of Norpace II. Angiology, 26: 106, 1975.

Gottdiener, J.S. , DiBianco. R. , Fletcher, R.D. , et al.: Effects of disopyramide on left ventricular function: Assessment by radionuclide cineangiography. Circulation, 62: 147, 1980.

Cathcart-Rake, W.F. , Coker, J.E. , Atkins, F.L. , et al.: The effect of concurrent administration of propranolol and disopyramide on cardiac function in healthy men. Circulation, 61: 938, 1980.

Harrison, D.C. , Winkle, R. , Sami, M. et al.: Encainide: A new and potent antiarrhythmic agent. Am. Heart J., 100: 1046, 1980.

DiBianco, R. , Gottdiener, J.S. , Fletcher, R.D. , et al.: Effects of encainide on left ventricular function: Assessment with treadmill exercise and radionuclide ventriculography. Circulation, 62: 182, 1980.

Pozenel, H. : Hemodynamic studies on mexilitene: A new antiarrhythmic agent. Postgrad. Med. J., 53: Suppl. 1, 78, 1977. 37. Jewitt, D.E. : Hemodynamic effects of newer antiarrhythmic drugs. Am. Heart J., 100: 984, 1980.

Piessens, J. , Willems, J. , Vesteloot, H. : Effects of aprindine on left ventricular contractility in man. Acta Cardiol., 18: (suppl.), 195, 1974.

Remme, W.J. , Verdouw, P.D. : Cardiovascular effects of aprindine. A new antiarrhythmic drug. Eur. J. Cardiol., 3: 307, 1975.

Nyquist, O. , Forssell, G. , Norlander, R. , et al.: Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction. Am. Heart J., 100: 1000, 1980.

Winkle, R.A. , Mason, J.W. , Harrison, D.C. : Tocainide for drug resistant arrhythmias: Efficacy, side effects and lidocaine responsiveness for predicting tocainide success. Am. Heart J., 100: 1031, 1980.

Frishman, W. , Silverman, R. , Strom, J. , et al.: Clinical pharmacology of the new beta adrenergic blocking. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker. Am. Heart J., 98: 256, 1979.

Greenblatt, D.J. , Koch-Weser, J. : Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program. Am. Heart J., 86: 478, 1973.

Marshall, R.C. , Berger, H.J. , Reduto, L.A. , et al.: Assessment of cardiac performance with quantitative radionuclide angiocardiography—Effects of oral propranolol on global and regional left ventricular function in coronary artery disease . Circulation, 58: 808, 1979.

Katz, R.J. , DiBianco, R. , Singh, S. , et al.: Acebutolol and left ventricular function: Assessment by radionuclide angiography. Clin. Pharmacol. Ther., 29: 149, 1981.

Chatterjee, K. , Mandel, W.J. , Vyden, J.K. , et al.: Cardiovascular effects of bretylium tosylate in acute myocardial infarction. JAMA, 223: 757, 1973.

Heissenbuttel, R.H. , Bigger, J.T. , Jr.: Bretylium tosylate, a newly available drug for ventricular arrhythmias. Ann. Intern. Med., 91: 229, 1979.

Sicart, M. , Besse, R. , Choussat, A. , et al.: Action hemodynamique de l'aminodarone chez diverses especes aminales et chez l'homme. Arch. Iat. Pharmacodyn. Ther., 177: 340, 1969.

Barzin, J. , Freson, A. : Essais diniques de l'aminodarone dans les affections coronariennes. Brux. Med., 49: 105, 1969.

Singh, B.N. , Ellrodt, G. , Peter, A. : Verapamil: A review of its pharmacologic properties and therapeutic use. Drugs, 15: 169, 1978.

Seabra-Gomes, R. , Rickards, A. , Sutton, R. : Hemodynamic effects of verapamil and practolol in man. Eur. J. Cardiol. 4: 79, 1976.